Did not become law. It stopped in the Senate's Health Care Committee on June 25, 2023. The 2023 session has ended.
2023 Regular Session
Senate Bill 716
Allows health care practitioner to prescribe or dispense drug for off-label indication.
What it does
The synopsis the Legislative Assembly published with the bill.
Allows health care practitioner to prescribe or dispense drug for off-label indication. Defines "off-label indication." Prohibits health professional regulatory board from disciplining health care practitioner for prescribing or dispensing drug for off-label indication. Allows pharmacist to dispense drug prescribed for off-label indication. Prohibits State Board of Pharmacy from disciplining pharmacist for dispensing drug prescribed for off-label indication. Takes effect on 91st day following adjournment sine die.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor
Its course
January 9 to June 25, 2023, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action3 actions on 3 days
In the SenateJan 9 to Jun 25 · stopped167 days
Waiting for a committeeJan 9 to Jan 134 days
Health CareJan 13 to Jun 25 · stopped163 days
Text
Each version as the Legislative Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.
In the Senate Jan 9 – Jun 25
- Jan 9Introduced
- Jan 13Sent to Health Care
- Jun 25Died when the session ended
All 3 actions, as published
- Jan 9Introduction and first reading. Referred to President's desk.Senate
- Jan 13Referred to Health Care.Senate
- Jun 25In committee upon adjournment.Senate